# OnCo record scott-antonia (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/scott-antonia/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "scott-antonia" ;
  schema:name "Scott J. Antonia"@en ;
  schema:description "Led PACIFIC, which made a year of durvalumab after chemoradiation the standard for stage III lung cancer."@en ;
  schema:url <https://onco.cc/people/scott-antonia/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Antonia%20SJ%5BAuthor%5D%20durvalumab%20PACIFIC> ;
  onco:tag "lung", "immunotherapy", "stage-iii" ;
  schema:jobTitle "Director, Center for Cancer Immunotherapy, Duke Cancer Institute" ;
  schema:sameAs <https://orcid.org/0000-0002-0029-9685> ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/sclc/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pdl1/> ;
  onco:drugs <https://onco.cc/drugs/durvalumab/>, <https://onco.cc/drugs/nivolumab/> ;
  onco:institutions <https://onco.cc/institutions/duke-cancer-institute/> ;
  onco:trials <https://onco.cc/trials/pacific/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-pacific-nejm-2017/> ;
  schema:affiliation <https://onco.cc/institutions/duke-cancer-institute/> .